Background
==========

The incidence rate for pancreatic cancer is approximately nine new cases per 100,000 people, with the peak incidence in the seventh and eighth decades of life and an average age of 60 to 65 years at diagnosis \[[@B1]\]. The commonest type is an adenocarcinoma.

Primary pancreatic leiomyosarcoma is a rare malignant neoplasm. It accounts for 0.1% of malignant pancreatic cancers \[[@B1]\]. A review of the literature reveals 22 such cases published so far \[[@B2]\]. The majority of the reported cases were diagnosed on autopsy.

Survival in patients with untreated PC is poor. For all stages combined, the 1-year survival rate is 19% and the 5-year survival rate is 4% \[[@B1]\]. The majority (80%) of PCs are metastatic at the time of diagnosis. Surgical resection (when margin negative, node negative) offers the best possibility for cure, with 5-year survival approaching 40% when performed at specialized major medical institutions \[[@B3]\].

We report a case of Primary leiomyosarcoma of Pancreas occurring in a 73 years old male.

Case presentation
=================

A 73 years old male presented with 1 month history of weight loss of 16 kilograms, epigastric pain, anorexia, abdominal fullness and jaundice. He was recently diagnosed with diabetes mellitus. Liver was palpable on examination of his abdomen. He had a raised bilirubin and liver enzymes. Abdominal ultrasound & CT scan demonstrated an enlarged liver containing multiple irregular ill defined lesions including the caudate lobe suggestive of metastases. There was a large enhancing soft tissue mass with a central necrotic area approximately measuring 9.4 × 10 cms in the region of the body of pancreas. This mass was compressing splenic artery and vein. The patient underwent Ultrasound guided liver biopsy. Histological & Immunohistochemical analysis confirmed leiomyosarcoma of the pancreatic origin. This case was discussed in relevant multidisciplinary team meeting. As his disease was already in advanced metastatic phase so he was offered palliative chemotherapy. His condition deteriorated before the chemotherapy & he died after 3 months of the initial diagnosis. No autopsy was conducted.

Histological examination was suggestive of Spindle cell neoplasm (Figures [1](#F1){ref-type="fig"} &[2](#F2){ref-type="fig"}). The spindle cells showed mild to moderate nuclear pleomorphism & anisocytosis. There was generally less than 1 mitotic figure per high power field & no abnormal mitotic figures were seen. The spindle cells were positive for desmin & smooth muscle actin. These were negative for cytokeratin (AE1/AE3), HMB45, S100 protein, melanin A, NSE (neuron specific enolase), CD34 and CD 117. The immune profile was suggestive of leiomyosarcoma.

![Photomicrograph of the liver biopsy stained with Haematoxylin and Eosin (H&E) Original magnification × 200.](1757-1626-1-280-1){#F1}

![Photomicrograph of the liver biopsy stained with smooth muscle actin (SMA) Original magnification × 200.](1757-1626-1-280-2){#F2}

In conclusion, the histological & Immunohistochemical features of the tumour were consistent with low to intermediate grade leiomyosarcoma.

Discussion
==========

Primary pancreatic leiomyosarcoma is a rare malignant neoplasm reported in world literature by only 22 cases up to this time.

We report a case of primary pancreatic leiomyosarcoma. This tumour was involving the body of the pancreas with direct invasion of the splenic vessels along with multiple hepatic secondaries. Complete clinical and radiological evaluation excluded secondary pancreatic involvement by a sarcoma of the retroperitoneal and gastrointestinal origin. Immunohistochemical analysis of the samples confirmed this tumour as a smooth muscle sarcoma.

Leiomyosarcomas involving pancreas consist of primary pancreatic leiomyosarcoma or pancreatic extensions of retroperitoneal and gastro-duodenal sarcomas \[[@B2]\]. Pancreatic mesenchymal tumours consist of malignant peripheral nerve sheath tumours, malignant fibrous histiocytomas, liposarcomas, rhabdomyosarcomas, hemipericytomas & leiomyosarcomas \[[@B3]\]. A detailed clinical evaluation is essential to rule out a primary extra pancreatic leiomyosarcomas. Female genital tract, gastrointestinal tract, soft tissues of the extremities and retroperitoneum are the most commonly affected areas \[[@B2]\].

Table [1](#T1){ref-type="table"} summarizes the clinicopathological data of the 22 reported cases of pancreatic leiomyosarcoma. Abdominal pain, weight loss, epigastric tenderness & abdominal mass are the most commonly presenting symptoms \[[@B4]\]. Pancreatic leiomyosarcoma is more common in fifth decade of life or older (mean age 44.7 years; range 14 to 80 years). Males are affected almost twice as compared to females (7:4). The size of the tumours is quite variable ranging from 3 cm to 25 cm (Median,10.5 cm). It is observed that larger tumour can develop cystic degeneration & can be misdiagnosed as pseudocysts of pancreas \[[@B4]\].

###### 

Clinicopathological data of reported cases.

  **Case Number**   **Year**   **Author**                **Age/Sex**             **Clinical features**                          **Morphological Findings**                                              **Clinical management & outcome**
  ----------------- ---------- ------------------------- ----------------------- ---------------------------------------------- ----------------------------------------------------------------------- -------------------------------------------------------------------------------------
  1                 1951       Ross                      80/M                    Weight loss, mass, LUQ                         Whole pancreas; wide spread metastases without lymph node involvement   Autopsy case
  2                 1956       Berman & Levene           47/M                    Jaundice                                       Head of pancreas;5.5 cm; no metastases                                  Pancreatodudenectomy ; well 1 year later
  3                 1957       Feinberg et al            14/M                    Epigastric pain; nausea                        Head;11 cm; no metastases                                               Pancreatodudenectomy
  4                 1965       Becker et al              No data available       No data available                              Cystic change                                                           No data available
  5                 1970       Oyamada et al             47/M                    General fatigue, mass, LUQ                     15 cm                                                                   Nonresectable
  6--10             1973       Baylor & Berg (5 cases)   51 (Median), M:3, F:2   No data available                              Localized:1;Locally advanced:1;Disseminated:3                           No data available
  11                1976       Carda et al               56/F                    Nausea & vomiting                              Whole pancreas                                                          Gastrostomy; died in 9 months
  12                1981       Ishikawa et al            44/M                    Epigastric pain, mass                          Head;8 cm,; localized at operation                                      Pancreatodudenectomy; liver metastases 4 years later
  13                1982       Tulha et al               28/F                    Weight loss, mass                              Head;20 cm                                                              Pancreatodudenectomy ; Lung & liver metastases 15 months later
  14                1990       Murata et al              55/F                    No data available                              Head & tail; no metastases                                              Caudal pancreatectomy
  15                1991       Lakhoo & Mannell          68/M                    Abdominal pain, weight loss, mass              Body;17 cm; no metastases                                               Distal pancreatectomy, gastric resection & transverse colectomy; well 2 years later
  16                1993       De Alava et al            71/M                    Abdominal pain, weight loss                    Body;3.6 cm; no metastases                                              Pancreatectomy
  17                1994       Peskova & Fried           68/F                    Malena                                         Head;15 cm; localized                                                   Pancreatodudenectomy;well 3 years later
  18                1994       Sato et al                53/F                    Abdominal pain, mass                           Body;25 cm; no metastases                                               Distal pancreatectomy
  19                1994       Ishii et al               66/M                    Incidental finding                             Tail;14 cm; wide spread metastases without lymph node involvement       Nonresectable
  20                1995       Aranha et al              46/F                    Epigastric pain, nausea, vomiting              Body;3 cm; localized                                                    Distal pancreatectomy; dead in 9 months
  21                1997       Owen et al                40/M                    Abdominal pain                                 Head;6 cm; no metastases                                                Pancreatodudenectomy; well 10 year later
  22                2000       Nesi et al                76/M                    Fever                                          Tail;8 cm; localized                                                    Distal pancreatectomy; dead in 12 months
  23                2007       Present case              73/M                    Weight loss, Epigastric pain, abdominal mass   Body;10 cm, hepatic metastases                                          Nonresectable; dead in 3 months

In the documented literature, about 43.5% (10 patients) presented with locally advanced or metastatic disease. First ever case of pancreatic leiomyosarcoma was diagnosed on autopsy \[[@B5]\]. Three patients died at 3,9 and 33 months respectively after the diagnosis \[[@B6],[@B7]\]. We do not know precisely about the survival outcome of remaining 6 patients.

At the time of diagnosis of leiomyosarcoma, only 13 cases seem to be localised to pancreas & underwent surgical resection. Followup details are available for only 8 patients. Four patients died of their tumours with in four years time after the initial diagnosis \[[@B6],[@B8],[@B9]\]. Remaining 4 patients were alive & free of symptoms at 1,3,4,6 years after the initial surgical management \[[@B10]-[@B12]\].

Large tumour size is not a precise predictor of adverse outcome. In leiomyomatous tumours mitotic figures are proposed to present the important predicting parameter \[[@B13]\]. Mitotic counts of more than 10 mitoses/10 HPFs is associated with a worse outcome \[[@B2]\].

Conclusion
==========

The number of cases of pancreatic leiomyosarcoma reported in world literature is limited but what we have learnt that it is a highly malignant tumour which can be metastatic even on first presentation. Extensive surgical resection of tumour is still the best treatment option for localised disease. Metastatic pancreatic leiomyosarcomas have shown only a partial response to chemotherapy.

Treatment is aimed at symptomatic improvement and pain management.
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